Peter Liu a University of Calgary graduate was highly commended in the Medical Sciences category in 2015 for his paper, “Augmentation of Oncolytic Viral Therapy by Immune Checkpoint Blockade and Reversal of Tumor Microenvironment Immunosuppression in Breast Cancer”.
Peter was an exchange scholar at Harbin Medical University the summer when he was ranked in highly commended in the medical science category, and his research done in China has since resulted in a second author publication in the Journal of Ovarian Research. The thesis submitted to the UA has also contributed to another scientific article that has been submitted for publication.
He has since completed two years of Doctor of Medicine (MD) education at the University of Toronto and currently studying for a DPhil in Clinical Medicine at the University of Oxford with Profs. Jane McKeating and Sir Peter Ratcliffe on how hepatitis viruses are able to exploit the oxygen-sensing pathway (hypoxia pathway) to induce liver cancer. Peter will complete the final two years of the MD Program thereafter as a part of his training as a physician-scientist.
He has also been involved with founding a Think Tank called BRIGHT International (http://brightinternational.org) to help more effectively and rapidly translate scientific innovation into practical applications in healthcare and medicine.
“So overall, I have been continuing to pursue cancer research as a career and hoping to contribute my part to bring the most innovative scientific discoveries to patients as a physician-scientist in the future.”